Amanda Ouchida
Senior Scientist Takeda
Seminars
Thursday 30th July 2026
Roundtable discussions: Building a General Consensus on Model Selection Criteria Across the Industry
11:30 am
- What are the pros and cons of the most implemented models?
- Exploring the various questions and contexts of use for each main model type and how translatable and clinically relevant they truly are
- How did you overcome hurdles encountered with your model when trying to better understand your drug/target?
Cell lines; In Vivo CDX, PDX, Transgenic, GEMMs; Ex Vivo/3D cultures; Computational/ In Silico
